Logo

Axxam to Provide Assays for NIH s Molecular Initiative

Jan 09, 2006

NEW YORK, Jan. 9 (GenomeWeb News) - Axxam will provide the National Institutes of Health with assays to be used in screening campaigns within the Molecular Libraries Roadmap Initiative, the company said today.

 

The screening assays were developed and optimized at Axxam for ultra high-throughput screening applications using ultra sensitive signal-detection methods.

 

The selection would be available to the NIH Chemical Genomics Center.

 

Financial details were not disclosed.

Breaking News
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.